• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Delayed introduction of immunosuppressive regimens in critically ill patients after liver transplantation

    2017-10-09 01:35:53YingLuoWenBinJiWeiDongDuanXianJieShiandZhiMingZhao

    Ying Luo, Wen-Bin Ji, Wei-Dong Duan, Xian-Jie Shi and Zhi-Ming Zhao

    Beijing, China

    Delayed introduction of immunosuppressive regimens in critically ill patients after liver transplantation

    Ying Luo, Wen-Bin Ji, Wei-Dong Duan, Xian-Jie Shi and Zhi-Ming Zhao

    Beijing, China

    METHODS: From March 2009 to February 2014, 225 consecutive liver recipients in our institute were included.e delayed administration of immunosuppressive regimens was attempted in 11 liver recipients with multiple severe comorbidities.

    (Hepatobiliary Pancreat Dis Int 2017;16:487-492)

    infection;

    immune monitoring;

    liver transplantation;

    immunosuppression;

    critical care;

    Immuknow assay

    Introduction

    Due to the lack of donor organs, a large proportion of patients with advanced chronic liver disease or acute liver failure develop multiple organ dysfunction before liver transplantation.[1-3]With respect to the post-transplant critical care of these patients, we have to weigh in two different biological systems, the newly implanted allograand the critically ill patient. On the one hand, the immunosuppressive strategies are mandatory in order to protect the allografrom rejection. On the other hand, the numerous adverse events associated with immunosuppressive regimens, such as infections,renal toxicity, neurologic toxicity etc,[4-6]significantly increased the risks of morbidities in these critically ill patients. Since the early 2009, we have attempted to delay the administration of immunosuppressive regimens in the critically ill patients aer liver transplantation under immune monitoring with ImmuKnow assay. In the present study, we aimed to evaluate the outcomes of this strategy in liver transplantation.

    Methods

    Patients

    From March 2009 to February 2014, 225 consecutive liver recipients in our institute were included. Eleven deceased donor liver recipients developed severe infection or multiple organ failure aer transplantation, including acute renal failure, severe encephalopathy, or respiratoryfailure. To avoid the adverse effects of immunosuppression, we attempted to delay the administration of immunosuppressive regimens in these critically ill patients.Demographics of the patients are shown in Table.ere were 7 males and 4 females, with an average age of 47.9 years (range 32-67). Two of them were alcoholic liver cirrhosis, 9 were acute-on-chronic liver failure (ACLF)rooted by hepatitis B virus (HBV) infection.e average score of model for end-stage liver disease (MELD) was 35 (range 18-45) before transplantation.e major reasons of delayed administration of immunosuppressive drugs are intra-abdominal infection, sepsis, acute renal failure and hepatic encephalopathy (n=1), sepsis and acute renal failure (n=1), acute renal failure and pulmonary infection (n=6), acute renal failure, encephalopathy,pulmonary infection and sepsis (n=3). Before transplantation, 3 patients developed hepatic encephalopathy of grade 3 (n=2) or grade 4 (n=1) requiring intubation and mechanical ventilation.e patient, who developed post-transplant intra-abdominal infection, sepsis, acute renal failure and encephalopathy, had been treated in another institute for decompensated alcoholic liver cirrhosis and primary peritonitis at 1 month before liver transplantation.e diagnosis of sepsis was based on the clinical manifestations, significantly increased levels of C-reactive protein and procalcitonin, and subsequent positive results of blood culture.e definitions and classifications of hepatic encephalopathy and acute renal failure were based on the West Haven criteria[7]and the risk, injury, failure, loss, and end-stage kidney disease criteria,[8]respectively.

    ImmuKnow assay

    For the early detection of acute allograrejection,continuous intensive monitoring of hepatic biochemistry was mandatory during the non-immunosuppression period, including serum aminotransferase, alkaline phosphatase, glutamyltranspeptidase, and bilirubin levels. CD4 T lymphocyte function assay (ImmuKnow, Catalogue No. 4400, Cylex Inc., Columbia, MD, USA) was routinely performed every three days, in addition to any occasion when there was a significant increase in liver enzyme levels.e assay's ability to discern between immune profiles of overimmunosuppression and underimmunosuppression has been reported in previous studies.[9-12]Briefly,100 μL whole blood (1:4 dilution) was added into wells of a 96-well microtiter plate in quadruplicate, and was incubated overnight (15-18 hours) in a 5% CO2incubator at 37 ℃ with or without phytohemagglutinin (PHA, 2.5 μg/mL) as a stimulant. Anti-human CD4 monoclonal antibody coated magnetic particles (Dynal, Oslo, Norway)were added to immunoselect CD4 cells from both the stimulated and nonstimulated wells. Aer washing the selected CD4 cells, a lysing reagent was added to release intracellular adenosine triphosphate (ATP). A luciferin/luciferase mixture was then added to the cell lysate.Within 10 minutes aer addition of enzyme, the bioluminescent product was measured in a luminometer.e amount of light emitted was compared with a calibration curve generated with ATP calibrators (0, 1, 10, 100 and 1000 ng/mL).e concentration of ATP (ng/mL) in each sample was then calculated from the calibration curve. According to the instruction of Cylex Immu-Know assay, the cut-offlevels are ≤225 ng/mL for low immune cell response, 226-524 ng/mL for moderate immune cell response, and ≥525 ng/mL for strong immune cell response, respectively. Twenty liver recipients with stable clinical status and 20 healthy people were included in the study as control groups.e median time aer liver transplantation was 22.3 months (range 18-56) in the liver recipient with stable status.

    Perioperative management

    Statistical analysis

    Nonparametric tests were used for statistical analysis.e Mann-WhitneyUtest and Wilcoxon test were used to compare continuous variables, and proportionswere compared by Chi-square test (SPSS/PC+; SPSS, Inc.,Chicago, IL, USA). APvalue of less than 0.05 was considered statistically significant.

    Results

    Clinical outcomes

    All transplants were performed with ABO-compatible whole gras.ere was 1 perioperative death.e patient died of multiple organ failure with concurrent confirmed sepsis 14 days aer liver transplantation, and the remaining patients were in good status and had normal grafunction during a median follow-up period of 43 months (range 8-64).e median length of intensive care unit (ICU) and hospital stay were 17 days (range 11-32) and 27 days (range 14-65), respectively (Table).e prolonged mechanical ventilation was required in all patients due to unstable mental status and/or respiratory failure secondary to infection or adult respiratory distress syndrome.e median duration of mechanical ventilation was 8 days (range 2-28), and tracheostomy was performed in 2 patients. Of the 11 patients, 10 received continuous renal replacement therapy (CRRT) due to acute renal failure.e median length of CRRT was 9 days (range 2-26).

    All of the 11 patients had culture-proven infections during the early period aer liver transplantation.e major morbidity was pulmonary infection (81.8%, 9/11),which may be resulted from liver failure, prolonged mechanical ventilation, and the complexity and urgent status of surgical procedure. Five patients developed systemic sepsis withStaphylococcus aureus(n=2),Enterococcus(n=1),Enterobacter(n=1), andEnterobacterandAspergillusspecies (n=1). Antimicrobial treatment was adjusted in 4 patients based on susceptibility testing,including vancomycin, tigecycline, carbapenems with or without trimethoprim sulfamethoxazole. In those patients receiving CRRT, the daily doses of antibiotics were based on local practice guidelines and published recommendations,[13]and each antibiotic was administered as a prolonged infusion of 4-6 hours. One patient developed intra-abdominal abscess, and was treated with percutaneous drainage guided by ultrasonography.

    Table.e demographic data of liver transplant recipients

    Table.e demographic data of liver transplant recipients

    LT: liver transplantation; HBV: hepatitis B virus; MELD: model for end-stage liver disease; ICU: intensive care unit; CRRT: continuous renal replacement therapy.

    CharacteristicsData (n=11)Average age (yr)47.9 (32-67)Gender (male/female) 7/4 Underlying liver diseases before LT Alcoholic liver cirrhosis 2 Acute liver failure on chronic HBV infection 9 Average MELD score before LT35 (18-45)Comorbidities aer LT Intra-abdominal infection 1 Sepsis 5 Pulmonary infection 9 Acute renal failure11 Encephalopathy 4 Median ICU stay (d)17 (11-32)Median hospital stay (d)27 (14-65)Median duration of mechanical ventilation (d) 8 (2-28)Median duration of CRRT (d) 9 (2-26)Median duration of non-immunosuppression (d)12 (5-58)

    T cell-mediated immune response

    Before transplantation, these critically ill patients presented a significantly lower ATP level of 286±101 ng/ mL as compared with healthy people with ATP level of 421±145 ng/mL in ImmuKnow assay (P<0.05), and then, the ATP level decreased to 64±35 ng/mL at day 3 post-transplant when all of the patients showed symptoms of infection (Fig. 1).e sequential tests showed that there was a distinct increase in the ATP level aer the system infections were controlled and the general status of patients were improved (Figs. 2 and 3). More importantly, the increase of ATP level was followed by the development of acute rejection against the allogras(Fig. 3).e average ATP level measured just before the development of acute rejection was 271±115 ng/mL(Fig. 1). A continuous distinct elevation of both ATP and glutamyltranspeptidase levels was a strong indication of the occurrence of acute rejection.e highest Immu-Know value was 510±173 ng/mL during the episodes of acute rejection, and was significantly higher than thatof the post-transplant recipients with clinical stability(247±123 ng/mL,P<0.05).e median non-immunosuppressed duration was 12 days (range 5-58) in the 11 patients aer transplantation (Table). Grade I or II acute grarejection was identified in all of these patients by pathological analysis based on BanffSchema. Aer the administration of immunosuppressive agents, the acute rejection was completely reversed in the 10 patients who survived perioperatively.

    Fig. 1.ImmuKnow measurements in healthy people, liver recipients with clinical stability, and critically ill patients at different time points. LT: liver transplantation; AR: acute rejection. *:P<0.05, compared with healthy control; #:P<0.05, compared with stable recipients.

    Fig. 2.Serial changes of ImmuKnow value in 11 critically ill patients aer liver transplantation.

    Fig. 3.A 60-year-old female patient, who underwent liver transplantation for acute liver failure on chronic HBV infection, developed pulmonary infection, sepsis, encephalopathy and acute renal failure at the early stage after transplantation. Blood and sputum culture tests showedEnterobacter,AspergillusandStreptococcusspecies infection. She was mechanically ventilated because of hepatic encephalopathy before transplantation, and received continuous renal replacement therapy (CRRT) immediately after transplantation. The duration of mechanical ventilation and CRRT were 28 and 17 days, respectively.e immunosuppressive regimens including cyclosporine and mycophenolate mofetil were administered at day 30 aer transplantation.A: Serial changes of ImmuKnow and hepatic biochemistry levels aer liver transplantation;B: Chest X-ray at different time points aer liver transplantation. ALT: alanine aminotransferase; γ-GT: glutamyltranspeptidase; ATP: adenosine triphosphate.

    Discussion

    Despite the fact that the graand patient survival aer liver transplantation has significantly improved during the past decades, the perioperative care of recipients with multiple comorbidities and organ dysfunction remains challenging.[14-17]Infectious complications are leading causes of morbidity and mortality in these recipients. Effective critical care during the immediate posttransplant recovery period results in good outcomes. A better understanding and application of immunosuppressive strategies plays an important role in the posttransplant intensive care of the critically ill patients. As these critically ill patients are vulnerable to infections and organ injury,the delayed administration or dose reduction of immunosuppressive drugs is oen required in clinical practice.[18]However, the duration of non-immunosuppression or low-dose immunosuppressives remains empirical.e transplant specialists have to balance between comorbidities and immunosuppressive therapy, especially in recipients with infectious complications. For minimizing the adverse effects of immunosuppressive drugs, criteria are needed to treat the critically ill patients individually according to their own immune status.

    It has been reported that the Cylex ImmuKnow assay,which was approved by the USA Food and Drug Administration in 2002, has the potential to serve as an index of the immune status of organ transplant recipients receiving immunosuppressive therapy.[9,19-22]e assay quantifies the cell-mediated immunity by measuring the concentration of ATP from circulating CD4 T cells aerin vitrostimulation with PHA.e present study assessed the clinical relevance and reliability of the ImmuKnow assay as an immune monitoring tool in the critically ill patients aer liver transplantation. We found that the ImmuKnow ATP values can represent the level offunctional immunity of the patients. At the early stage aer transplantation, all of these critically ill recipients showed a significantly low degree of global immune response.is phenomenon may be associated with the development of infectious diseases. Importantly, there were no any signs of allograrejection in these patients.erefore, the immunosuppressive regimens were not administered in all of them during the early period aer transplantation in order to avoid the drug toxicity and the exacerbation of infectious diseases due to the immunosuppression.e median duration of non-immunosuppression was 12 days (5-58).is gives the ICU physicians very valuabletime to treat the recipients with multiple comorbidities and organ dysfunction.

    In addition, the longitudinal ImmunKnow assay provided a reliable depiction of the dynamics offunctional immunity throughout the clinical course of the patients.We found that a continuous distinct elevation of both ATP and glutamyltranspeptidase levels was a strong indication of the development of acute rejection.is is very helpful in optimizing a favorable timing of introduction of the immunosuppressive therapy. Fig. 3 described a 60-year-old female patient who suffered from pulmonary infection, sepsis, encephalopathy and acute renal failure at the early stage aer transplantation.e longitudinal immune monitoring with ImmuKnow assay showed a significant correlation with the clinical episodes of the patient. Both the amelioration of comorbidities and the development of acute rejection were parallel to the distinct changes of the ImmuKnow value. Another 32-yearold male patient with alcoholic cirrhosis, who developed intra-abdominal infection, sepsis, acute renal failure and encephalopathy aer liver transplantation, had significantly low ImmuKnow ATP levels and nearly normal hepatic biochemistry during the early period aer transplantation. His ATP level started to increase significantly aer 50 days of liver transplantation.e immunosuppressive regimens were administered at day 58 aer transplantation when the acute allograrejection was identified (data not shown).ese results are comparable with the other reports, suggesting that the ImmuKnow assay could serve as an immune monitoring tool in organ transplant recipients.[9,10,19,20]In previous studies, the investigators have attempted to stratify patient's immune status using ImmuKnow assay.[9,19]In our experiences,however, both the inter-individual and the intra-individual deviations of ImmuKnow measurements were large.e serial longitudinal ImmuKnow measurements and analyses of the changes of ATP levels over time were more informative in identification of clinical adverse events including infectious diseases or acute rejection than a single measurement.

    In conclusion, the present study shows that the delayed introduction of immunosuppressive regimens is safe and effective in management of critically ill patients aer liver transplantation.e longitudinal immune monitoring with ImmuKnow assay may be helpful in optimizing the timing of introduction of immunosuppression by providing the status of the functional immunity of a given critically ill recipient.

    Contributors:LY proposed and performed the study, and wrote the dra. JWB performed the study and revised the paper. DWD performed the study and collected the data. SXJ performed the study. ZZM collected the data. All authors contributed to the design and interpretation of the study and to further dras. LY is the guarantor.

    Funding:None.

    Ethical approval:e study was conducted according to theDeclaration of Helsinkiand was approved by the Ethics Committee of Chinese PLA General Hospital, Beijing, China.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Findlay JY, Fix OK, Paugam-Burtz C, Liu L, Sood P, Tomlanovich SJ, et al. Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl 2011;17:496-510.

    2 Keegan MT, Kramer DJ. Perioperative care of the liver transplant patient. Crit Care Clin 2016;32:453-473.

    4 Umbro I, Tinti F, Scalera I, Evison F, Gunson B, Sharif A, et al.Acute kidney injury and post-reperfusion syndrome in liver transplantation. World J Gastroenterol 2016;22:9314-9323.

    5 Pedersen M, Seetharam A. Infections aer orthotopic liver transplantation. J Clin Exp Hepatol 2014;4:347-360.

    6 Derle E, Kibaro?lu S, ?cal R, K?rnap M, Can U, Benli S, et al.Neurologic complications aer liver transplant: experience at a single center. Exp Clin Transplant 2015;13:327-330.

    7 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K,Blei AT. Hepatic encephalopathy--definition, nomenclature,diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna,1998. Hepatology 2002;35:716-721.

    8 Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure -definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative(ADQI) Group. Crit Care 2004;8:R204-212.

    9 Israeli M, Klein T, Sredni B, Avitzur Y, Mor E, Bar-Nathen N,et al. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl 2008;14:893-898.

    10 Xue F, Zhang J, Han L, Li Q, Xu N, Zhou T, et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation 2010;89:620-626.

    11 Ravaioli M, Neri F, Lazzarotto T, Bertuzzo VR, Di Gioia P,Stacchini G, et al. Immunosuppression modifications based on an immune response assay: results of a randomized, controlled trial. Transplantation 2015;99:1625-1632.

    12 Sugiyama K, Tsukaguchi M, Toyama A, Satoh H, Saito K, Nakagawa Y, et al. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor. Exp Clin Transplant 2014;12:195-199.

    13 Trotman RL, Williamson JC, Shoemaker DM, Salzer WL. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. Clin Infect Dis 2005;41:1159-1166.

    14 Niemann CU, Kramer DJ. Transplant critical care: standards for intensive care of the patient with liver failure before and aer transplantation. Liver Transpl 2011;17:485-487.

    15 Razonable RR, Findlay JY, O'Riordan A, Burroughs SG, Ghobrial RM, Agarwal B, et al. Critical care issues in patients aer liver transplantation. Liver Transpl 2011;17:511-527.

    16 Carton EG, Plevak DJ, Kranner PW, Rettke SR, Geiger HJ,Coursin DB. Perioperative care of the liver transplant patient:Part 2. Anesth Analg 1994;78:382-399.

    17 Feltracco P, Barbieri S, Galligioni H, Michieletto E, Carollo C, Ori C. Intensive care management of liver transplanted patients. World J Hepatol 2011;3:61-71.

    18 Sood S, Testro AG. Immune monitoring post liver transplant.World J Transplant 2014;4:30-39.

    19 Israeli M, Ben-Gal T, Yaari V, Valdman A, Matz I, Medalion B,et al. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.Transplantation 2010;89:968-976.

    20 Uemura T, Riley TR, Khan A, Hollenbeak C, Schreibman I,Ghahramani N, et al. Immune functional assay for immunosuppressive management in post-transplant malignancy. Clin Transplant 2011;25:E32-37.

    21 Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transpl 2008;14:1313-1322.

    22 Hooper E, Hawkins DM, Kowalski RJ, Post DR, Britz JA,Brooks KC, et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 2005;19:834-839.

    September 7, 2016

    Accepted after revision May 25, 2017

    Author Affiliations: Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing 100853, China (Luo Y, Ji WB, Duan WD, Shi XJ and Zhao ZM)

    Ying Luo, MD, Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing 100853, China (Tel: +86-10-66938334; Fax: +86-10-68241383; Email: luoyingly@hotmail.com)

    ? 2017, Hepatobiliary Pancreat Dis Int. All rights reserved.

    10.1016/S1499-3872(17)60050-X

    Published online August 8, 2017.

    日本五十路高清| 啦啦啦视频在线资源免费观看| cao死你这个sao货| 大香蕉久久网| 男人舔女人的私密视频| 天堂8中文在线网| 亚洲欧洲日产国产| 成人手机av| 免费高清在线观看日韩| 91成人精品电影| 精品福利观看| 青青草视频在线视频观看| 国产亚洲欧美精品永久| 国产精品成人在线| 男女边摸边吃奶| 国产在线免费精品| 美女午夜性视频免费| 亚洲欧美精品综合一区二区三区| 亚洲av电影在线观看一区二区三区| 啦啦啦在线观看免费高清www| 精品国产乱码久久久久久小说| 狠狠婷婷综合久久久久久88av| 欧美人与善性xxx| 久久精品熟女亚洲av麻豆精品| 91成人精品电影| 十八禁高潮呻吟视频| 欧美成人精品欧美一级黄| 国产精品久久久久久精品电影小说| 王馨瑶露胸无遮挡在线观看| 久久久精品94久久精品| 熟女少妇亚洲综合色aaa.| 欧美成狂野欧美在线观看| 母亲3免费完整高清在线观看| 午夜福利在线免费观看网站| 美女中出高潮动态图| 国产精品一二三区在线看| 欧美日韩国产mv在线观看视频| 亚洲免费av在线视频| 一级,二级,三级黄色视频| 国产亚洲欧美在线一区二区| 免费看不卡的av| 国产精品久久久av美女十八| 飞空精品影院首页| 精品久久久精品久久久| 国产成人啪精品午夜网站| 亚洲一卡2卡3卡4卡5卡精品中文| 亚洲五月婷婷丁香| 90打野战视频偷拍视频| 性高湖久久久久久久久免费观看| 一区二区日韩欧美中文字幕| 婷婷色av中文字幕| 9热在线视频观看99| 我的亚洲天堂| www.精华液| 成人国语在线视频| 亚洲一码二码三码区别大吗| 亚洲av日韩精品久久久久久密 | avwww免费| 亚洲伊人色综图| 悠悠久久av| 日韩中文字幕欧美一区二区 | 国产精品av久久久久免费| 亚洲精品美女久久av网站| 国产精品麻豆人妻色哟哟久久| 美女午夜性视频免费| 999精品在线视频| 欧美中文综合在线视频| xxx大片免费视频| av片东京热男人的天堂| 午夜老司机福利片| 国产一区二区三区av在线| 在线看a的网站| 久久女婷五月综合色啪小说| 捣出白浆h1v1| 狠狠精品人妻久久久久久综合| www日本在线高清视频| 国产在视频线精品| 国产av国产精品国产| 成人国产av品久久久| 亚洲精品国产色婷婷电影| 欧美中文综合在线视频| 久久午夜综合久久蜜桃| www.熟女人妻精品国产| 日本猛色少妇xxxxx猛交久久| 熟女少妇亚洲综合色aaa.| 亚洲伊人久久精品综合| 久久精品成人免费网站| 日本a在线网址| 丝袜美腿诱惑在线| 性高湖久久久久久久久免费观看| 国产欧美亚洲国产| 男女床上黄色一级片免费看| 国产91精品成人一区二区三区 | 国产极品粉嫩免费观看在线| 亚洲一区二区三区欧美精品| 黑丝袜美女国产一区| 看免费成人av毛片| av有码第一页| 国产精品九九99| 久久精品国产亚洲av涩爱| 国产真人三级小视频在线观看| 国产精品久久久av美女十八| 久久亚洲精品不卡| 青春草视频在线免费观看| 国产亚洲精品第一综合不卡| 亚洲av在线观看美女高潮| 在线观看www视频免费| 亚洲欧美日韩另类电影网站| 我要看黄色一级片免费的| 一区二区三区四区激情视频| 国产精品人妻久久久影院| 一区二区av电影网| 久9热在线精品视频| 欧美日韩福利视频一区二区| 日本av免费视频播放| 亚洲精品自拍成人| 最新的欧美精品一区二区| 国产av精品麻豆| 国产男女超爽视频在线观看| 啦啦啦 在线观看视频| 国产欧美日韩一区二区三 | 国产精品一区二区在线不卡| 久久青草综合色| 亚洲 欧美一区二区三区| 精品第一国产精品| 色综合欧美亚洲国产小说| 午夜久久久在线观看| 在线观看国产h片| 黄色怎么调成土黄色| 一区二区三区四区激情视频| 无限看片的www在线观看| 99久久99久久久精品蜜桃| 人妻人人澡人人爽人人| 男人爽女人下面视频在线观看| 在线 av 中文字幕| 热re99久久精品国产66热6| 亚洲国产精品国产精品| 极品少妇高潮喷水抽搐| 欧美av亚洲av综合av国产av| av天堂在线播放| tube8黄色片| 精品亚洲乱码少妇综合久久| 18禁观看日本| 免费在线观看影片大全网站 | 国产在线一区二区三区精| 精品国产一区二区三区四区第35| av在线老鸭窝| 久久久欧美国产精品| 国产一卡二卡三卡精品| 亚洲男人天堂网一区| 精品少妇黑人巨大在线播放| 久久av网站| www.999成人在线观看| 捣出白浆h1v1| 人人妻人人爽人人添夜夜欢视频| 人人妻人人爽人人添夜夜欢视频| 国产三级黄色录像| 永久免费av网站大全| 国产精品国产三级专区第一集| 精品国产乱码久久久久久男人| 18在线观看网站| 成年人黄色毛片网站| 免费不卡黄色视频| 成人18禁高潮啪啪吃奶动态图| 中文字幕高清在线视频| 丝袜脚勾引网站| 人妻 亚洲 视频| 在线观看免费视频网站a站| 国产av一区二区精品久久| 中文字幕人妻丝袜一区二区| 国产不卡av网站在线观看| 亚洲精品美女久久久久99蜜臀 | 久久综合国产亚洲精品| 久久久国产一区二区| 国产高清videossex| 国产精品人妻久久久影院| 久久人人爽av亚洲精品天堂| 亚洲精品国产av成人精品| 蜜桃国产av成人99| 亚洲成人免费av在线播放| 国产91精品成人一区二区三区 | 一区二区三区乱码不卡18| 国产亚洲一区二区精品| 97在线人人人人妻| 亚洲成人国产一区在线观看 | xxxhd国产人妻xxx| 婷婷色综合www| 精品国产超薄肉色丝袜足j| 在线观看一区二区三区激情| 国产xxxxx性猛交| 亚洲精品久久成人aⅴ小说| 捣出白浆h1v1| 亚洲欧美精品自产自拍| 美女主播在线视频| 高清av免费在线| 高清不卡的av网站| 美国免费a级毛片| 秋霞在线观看毛片| 亚洲图色成人| 精品视频人人做人人爽| 成人免费观看视频高清| 亚洲激情五月婷婷啪啪| 日本一区二区免费在线视频| 一级毛片电影观看| 久久青草综合色| 亚洲精品国产av成人精品| 久久久久网色| 国产精品一二三区在线看| 十八禁高潮呻吟视频| 欧美变态另类bdsm刘玥| 亚洲,欧美精品.| 大陆偷拍与自拍| 亚洲av国产av综合av卡| 人人妻人人澡人人看| 在线观看国产h片| 久久精品亚洲熟妇少妇任你| 婷婷成人精品国产| 免费少妇av软件| www.av在线官网国产| 色精品久久人妻99蜜桃| 中文字幕另类日韩欧美亚洲嫩草| 国产精品av久久久久免费| 一级片免费观看大全| 国产精品 国内视频| 国产伦人伦偷精品视频| 交换朋友夫妻互换小说| 国产av精品麻豆| 亚洲五月婷婷丁香| 菩萨蛮人人尽说江南好唐韦庄| 国产精品免费大片| 亚洲国产最新在线播放| 黄网站色视频无遮挡免费观看| 亚洲av成人不卡在线观看播放网 | 女人被躁到高潮嗷嗷叫费观| 久热这里只有精品99| 成年人免费黄色播放视频| 人成视频在线观看免费观看| 黄色片一级片一级黄色片| 国产精品人妻久久久影院| 亚洲精品av麻豆狂野| av不卡在线播放| 成年av动漫网址| 欧美人与善性xxx| 人成视频在线观看免费观看| 两人在一起打扑克的视频| 久久久久久久精品精品| 最近手机中文字幕大全| 韩国高清视频一区二区三区| 搡老岳熟女国产| 男女床上黄色一级片免费看| 永久免费av网站大全| 亚洲人成电影免费在线| 亚洲av电影在线观看一区二区三区| 欧美 亚洲 国产 日韩一| 亚洲av成人不卡在线观看播放网 | 悠悠久久av| 亚洲人成网站在线观看播放| 看免费成人av毛片| 男女边摸边吃奶| 在线av久久热| 国产av国产精品国产| 黄网站色视频无遮挡免费观看| 成人午夜精彩视频在线观看| 国产成人精品久久二区二区91| 一级毛片 在线播放| 久久国产亚洲av麻豆专区| 天堂俺去俺来也www色官网| 久久精品熟女亚洲av麻豆精品| 久久中文字幕一级| 麻豆国产av国片精品| 欧美国产精品一级二级三级| 免费日韩欧美在线观看| 国产亚洲午夜精品一区二区久久| 男女边吃奶边做爰视频| 91精品国产国语对白视频| 欧美成人午夜精品| 午夜福利视频在线观看免费| 亚洲久久久国产精品| 天天操日日干夜夜撸| 中文字幕人妻熟女乱码| 黑人猛操日本美女一级片| 最近手机中文字幕大全| 亚洲av片天天在线观看| 色播在线永久视频| 亚洲国产精品一区三区| 国产男人的电影天堂91| 极品人妻少妇av视频| 亚洲av男天堂| 亚洲美女黄色视频免费看| 母亲3免费完整高清在线观看| 午夜福利在线免费观看网站| 亚洲久久久国产精品| 人妻 亚洲 视频| 另类亚洲欧美激情| 国产xxxxx性猛交| 91成人精品电影| 波多野结衣av一区二区av| av在线app专区| 国产爽快片一区二区三区| 老熟女久久久| 新久久久久国产一级毛片| h视频一区二区三区| 亚洲视频免费观看视频| 精品视频人人做人人爽| 亚洲精品一二三| 赤兔流量卡办理| 国产女主播在线喷水免费视频网站| 精品欧美一区二区三区在线| 日本欧美国产在线视频| 一区二区日韩欧美中文字幕| 老司机影院毛片| 免费人妻精品一区二区三区视频| 黑人猛操日本美女一级片| 又紧又爽又黄一区二区| 两个人免费观看高清视频| 欧美激情高清一区二区三区| 日本vs欧美在线观看视频| svipshipincom国产片| 中文字幕精品免费在线观看视频| 亚洲成人免费av在线播放| 99国产综合亚洲精品| 日本wwww免费看| 国产成人精品久久二区二区免费| 久久久久久免费高清国产稀缺| 考比视频在线观看| 欧美精品人与动牲交sv欧美| 成年女人毛片免费观看观看9 | 日韩av在线免费看完整版不卡| 国产亚洲午夜精品一区二区久久| 99国产精品一区二区三区| 亚洲国产精品国产精品| 99re6热这里在线精品视频| 国产色视频综合| 50天的宝宝边吃奶边哭怎么回事| 97人妻天天添夜夜摸| 久久精品aⅴ一区二区三区四区| 成年美女黄网站色视频大全免费| 日本一区二区免费在线视频| xxxhd国产人妻xxx| 婷婷成人精品国产| 久久亚洲国产成人精品v| 一级片免费观看大全| 国产男人的电影天堂91| 欧美人与性动交α欧美软件| 亚洲av成人不卡在线观看播放网 | 国产主播在线观看一区二区 | 9191精品国产免费久久| 午夜视频精品福利| 91精品三级在线观看| 成人手机av| 久久影院123| 777久久人妻少妇嫩草av网站| 久久国产精品男人的天堂亚洲| 狠狠婷婷综合久久久久久88av| 成人国产av品久久久| 国产精品久久久av美女十八| 美女脱内裤让男人舔精品视频| 狂野欧美激情性xxxx| 9热在线视频观看99| 日韩精品免费视频一区二区三区| 国产精品久久久久久人妻精品电影 | 免费高清在线观看日韩| 老司机午夜十八禁免费视频| 少妇猛男粗大的猛烈进出视频| 国产深夜福利视频在线观看| 看十八女毛片水多多多| 亚洲国产av影院在线观看| 丁香六月欧美| 纯流量卡能插随身wifi吗| 黄色视频不卡| 亚洲国产av影院在线观看| 精品高清国产在线一区| 每晚都被弄得嗷嗷叫到高潮| 黑丝袜美女国产一区| e午夜精品久久久久久久| 久久精品亚洲熟妇少妇任你| 国产亚洲欧美在线一区二区| 国产高清videossex| 日本五十路高清| 久久人妻福利社区极品人妻图片 | 自线自在国产av| 中国美女看黄片| 美女国产高潮福利片在线看| 亚洲男人天堂网一区| 亚洲第一av免费看| 精品免费久久久久久久清纯 | 久久久久久久国产电影| 伊人亚洲综合成人网| 婷婷色综合www| 精品人妻熟女毛片av久久网站| 熟女少妇亚洲综合色aaa.| 日本五十路高清| 少妇裸体淫交视频免费看高清 | 欧美日韩视频高清一区二区三区二| 天天躁夜夜躁狠狠躁躁| 波野结衣二区三区在线| 可以免费在线观看a视频的电影网站| 一边摸一边做爽爽视频免费| 日本黄色日本黄色录像| 日韩制服骚丝袜av| 美国免费a级毛片| 成年动漫av网址| 亚洲人成电影观看| 男男h啪啪无遮挡| 日本五十路高清| 亚洲黑人精品在线| 精品一区二区三区av网在线观看 | 国产一区二区三区综合在线观看| 亚洲国产av影院在线观看| 国产精品99久久99久久久不卡| 99国产精品免费福利视频| 日韩制服骚丝袜av| 亚洲国产精品成人久久小说| 亚洲国产日韩一区二区| 国产男人的电影天堂91| 亚洲欧美激情在线| 波野结衣二区三区在线| 夫妻午夜视频| 亚洲精品国产av蜜桃| 满18在线观看网站| 脱女人内裤的视频| 丁香六月天网| 人成视频在线观看免费观看| 日日爽夜夜爽网站| 美女中出高潮动态图| 精品国产乱码久久久久久小说| 99久久99久久久精品蜜桃| av视频免费观看在线观看| 后天国语完整版免费观看| 亚洲国产最新在线播放| 男女无遮挡免费网站观看| 一区在线观看完整版| 9191精品国产免费久久| 成年动漫av网址| 婷婷色综合大香蕉| 免费在线观看视频国产中文字幕亚洲 | 久久99热这里只频精品6学生| 三上悠亚av全集在线观看| 99国产精品一区二区蜜桃av | 多毛熟女@视频| 亚洲av成人不卡在线观看播放网 | 午夜av观看不卡| 最黄视频免费看| 久久久久网色| 看免费成人av毛片| 啦啦啦在线观看免费高清www| 国产精品一区二区精品视频观看| 岛国毛片在线播放| 久久久国产一区二区| 少妇粗大呻吟视频| 性色av乱码一区二区三区2| 亚洲精品久久午夜乱码| 巨乳人妻的诱惑在线观看| 亚洲天堂av无毛| 老司机影院成人| www.999成人在线观看| 婷婷丁香在线五月| 少妇粗大呻吟视频| 男的添女的下面高潮视频| 99久久99久久久精品蜜桃| 日韩欧美一区视频在线观看| 人人妻人人澡人人看| 亚洲欧美日韩另类电影网站| 久久中文字幕一级| 免费在线观看日本一区| 久久精品熟女亚洲av麻豆精品| 亚洲欧美成人综合另类久久久| 亚洲五月色婷婷综合| 欧美日韩亚洲综合一区二区三区_| 欧美大码av| av欧美777| 精品久久久久久电影网| 国产亚洲av高清不卡| 国产福利在线免费观看视频| 男男h啪啪无遮挡| 久久天堂一区二区三区四区| av又黄又爽大尺度在线免费看| 亚洲精品国产av蜜桃| 成人黄色视频免费在线看| 精品少妇一区二区三区视频日本电影| 久久中文字幕一级| 国产av国产精品国产| 亚洲人成网站在线观看播放| 成人国产av品久久久| 色网站视频免费| 啦啦啦在线免费观看视频4| av视频免费观看在线观看| 一区二区av电影网| 日韩 亚洲 欧美在线| 欧美黑人精品巨大| 国产精品秋霞免费鲁丝片| 一区二区三区激情视频| 国产成人精品无人区| 中文字幕高清在线视频| 精品人妻熟女毛片av久久网站| svipshipincom国产片| 国产又爽黄色视频| 又大又黄又爽视频免费| 亚洲三区欧美一区| 大型av网站在线播放| 蜜桃在线观看..| 精品久久蜜臀av无| 久久人人97超碰香蕉20202| 两性夫妻黄色片| 国产黄色视频一区二区在线观看| 性色av乱码一区二区三区2| 免费一级毛片在线播放高清视频 | 大香蕉久久网| 黄色怎么调成土黄色| 欧美黑人精品巨大| 婷婷丁香在线五月| 伊人久久大香线蕉亚洲五| 日本色播在线视频| 国产精品国产三级国产专区5o| 欧美在线一区亚洲| 午夜91福利影院| 国产精品.久久久| 我的亚洲天堂| 亚洲成人国产一区在线观看 | 在线观看一区二区三区激情| 国产成人91sexporn| 三上悠亚av全集在线观看| 日本av免费视频播放| 精品少妇一区二区三区视频日本电影| 久久精品国产亚洲av高清一级| 黄色毛片三级朝国网站| www.999成人在线观看| 久久综合国产亚洲精品| 人妻 亚洲 视频| 国产男人的电影天堂91| 国产日韩欧美亚洲二区| 日韩制服骚丝袜av| 韩国精品一区二区三区| 99精品久久久久人妻精品| 黄网站色视频无遮挡免费观看| 日韩av不卡免费在线播放| 免费在线观看视频国产中文字幕亚洲 | 亚洲av综合色区一区| 亚洲五月婷婷丁香| 亚洲五月色婷婷综合| 天天躁夜夜躁狠狠久久av| av不卡在线播放| 少妇裸体淫交视频免费看高清 | 亚洲中文日韩欧美视频| 在线天堂中文资源库| 久久久久久久精品精品| 久久亚洲国产成人精品v| 欧美国产精品一级二级三级| 日韩电影二区| 各种免费的搞黄视频| 少妇精品久久久久久久| 七月丁香在线播放| 亚洲国产精品国产精品| 午夜老司机福利片| 日韩制服丝袜自拍偷拍| 国产一区二区在线观看av| 久久精品国产a三级三级三级| av福利片在线| 亚洲 国产 在线| 国产成人一区二区三区免费视频网站 | 久久人人爽人人片av| 亚洲精品日韩在线中文字幕| 97精品久久久久久久久久精品| 美女大奶头黄色视频| a 毛片基地| 亚洲一码二码三码区别大吗| 成年人午夜在线观看视频| 满18在线观看网站| av不卡在线播放| 成年美女黄网站色视频大全免费| 高清欧美精品videossex| 欧美激情高清一区二区三区| 国产在视频线精品| 久久精品国产亚洲av高清一级| 亚洲欧美清纯卡通| 久久中文字幕一级| 国产精品久久久久成人av| 国产亚洲精品久久久久5区| av不卡在线播放| 欧美xxⅹ黑人| www日本在线高清视频| 最近最新中文字幕大全免费视频 | 国产精品av久久久久免费| 99国产精品一区二区三区| 欧美精品一区二区大全| 老司机在亚洲福利影院| 1024视频免费在线观看| 亚洲熟女毛片儿| 成人黄色视频免费在线看| 亚洲国产成人一精品久久久| 国产欧美日韩综合在线一区二区| 晚上一个人看的免费电影| 亚洲国产av新网站| 欧美精品高潮呻吟av久久| 精品久久蜜臀av无| 男人添女人高潮全过程视频| 一级毛片电影观看| 亚洲,欧美,日韩| 中文字幕av电影在线播放| 午夜福利在线免费观看网站| 欧美 亚洲 国产 日韩一| 色精品久久人妻99蜜桃| 亚洲三区欧美一区| 欧美日韩视频精品一区| 亚洲 国产 在线| 在线av久久热| 美女中出高潮动态图| av一本久久久久| 高清视频免费观看一区二区| 国产成人av激情在线播放| 国产精品九九99| 咕卡用的链子| 亚洲一码二码三码区别大吗| 亚洲欧美日韩另类电影网站| 香蕉国产在线看|